Can a pericapsular nerve group (PENG) block be performed on a patient with an intertrochanteric femoral neck fracture who took Eliquis (apixaban) the night before?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

PENG Block After Recent Eliquis: Proceed with Caution Based on Timing and Apixaban Levels

A PENG block can be performed on a patient who took Eliquis the night before an intertrochanteric fracture, but only if the apixaban concentration is measured and confirmed to be below 30 ng/mL, or if at least 24 hours have elapsed since the last dose—otherwise, the procedure should be delayed or apixaban levels checked before proceeding. 1

Risk Classification and Decision Framework

The PENG block is classified as a neuraxial-adjacent procedure with high bleeding risk due to its proximity to neurovascular structures and the potential for uncontrollable bleeding in a deep fascial plane. The 2025 French guidelines explicitly address this scenario:

Timing-Based Approach

If the patient took Eliquis (apixaban) "the night before":

  • Minimum safe interval: The FDA label recommends discontinuing Eliquis at least 24 hours prior to procedures with low bleeding risk 2
  • For neuraxial procedures: The 2025 guidelines specify a 30 ng/mL threshold for neuraxial and intracranial procedures (stricter than the 50 ng/mL for other high-risk procedures) 1
  • Peak effect consideration: Apixaban peaks 3-4 hours post-dose, so "night before" likely means 8-16 hours elapsed—potentially insufficient clearance 1

Recommended Algorithm

Step 1: Measure apixaban anti-Xa concentration immediately 1

  • If < 30 ng/mL: Proceed with PENG block safely 1
  • If 30-50 ng/mL: High risk—delay if possible or consider alternative analgesia
  • If > 50 ng/mL: Do NOT perform the block 1

Step 2: If measurement unavailable, use time-based estimation:

  • < 24 hours since last dose: Delay the block if clinically feasible
  • ≥ 24 hours since last dose: Reasonable to proceed, but measure levels if available
  • Consider renal function: Check creatinine clearance—impaired renal function prolongs apixaban half-life and increases risk 1

Step 3: If the procedure cannot be delayed and levels exceed threshold:

  • The 2025 guidelines strongly recommend against neuraxial procedures even with PCC reversal due to spinal hematoma risk 1
  • Consider alternative analgesia: IV opioids, fascia iliaca block (more superficial, potentially lower risk), or general anesthesia for surgery 3

Critical Safety Considerations

Why PENG Blocks Are High-Risk on Anticoagulation

  • Anatomical location: The PENG block targets the space between the psoas tendon and pubic ramus, near the femoral neurovascular bundle 4, 5
  • Compressibility: Unlike peripheral nerve blocks in compressible sites, bleeding in this deep fascial plane is difficult to detect and control
  • Neuraxial proximity: While not technically neuraxial, the consequences of hematoma formation could be catastrophic

The 24-Hour Rule Is Insufficient Alone

The FDA label states 24 hours for "low bleeding risk" procedures 2, but:

  • PENG blocks carry higher bleeding risk than typical peripheral blocks
  • The 2025 guidelines emphasize that time alone is inadequate—concentration measurement is essential for high-risk procedures 1
  • Individual pharmacokinetics vary significantly, especially in elderly patients with hip fractures who often have renal impairment

Practical Implementation

For your specific patient with an intertrochanteric fracture:

  1. Obtain anti-Xa apixaban level stat (if available at your institution)
  2. Check renal function (CrCl via Cockcroft-Gault formula) 1
  3. Calculate time since last dose precisely (not just "night before")
  4. If < 30 ng/mL or > 24 hours with normal renal function: Proceed with PENG block 1
  5. If levels unavailable and < 24 hours: Use IV morphine or fascia iliaca block as bridge analgesia 3

Alternative Analgesic Strategy

Recent evidence shows PENG blocks provide superior analgesia to IV opioids 3, but if unsafe to perform:

  • IV morphine 0.1 mg/kg provides adequate pain control (though inferior to PENG) 3
  • Fascia iliaca block may be considered as a more superficial alternative, though less effective for intertrochanteric fractures
  • Multimodal analgesia: Acetaminophen, IV lidocaine infusion, ketamine as adjuncts

Common Pitfalls to Avoid

  • Assuming "night before" equals safe timing: Always calculate exact hours and measure levels when possible
  • Ignoring renal function: Elderly hip fracture patients frequently have CrCl < 50 mL/min, prolonging apixaban half-life significantly 1
  • Proceeding without measurement in high-risk patients: The 2025 guidelines represent the most current evidence and explicitly require concentration measurement for neuraxial-adjacent procedures 1
  • Using PCC as a safety net: The guidelines state PCC does not make neuraxial procedures safe and should not be relied upon 1

The evidence strongly supports measuring apixaban levels before proceeding with PENG blocks in patients with recent Eliquis exposure, particularly given the catastrophic consequences of spinal/epidural hematoma in this vulnerable elderly population. 1

Related Questions

In a 77-year-old postoperative femoral neck fracture patient prescribed aspirin (81 mg twice daily) for four weeks for deep vein thrombosis prophylaxis, should a proton‑pump inhibitor be added?
In an 86-year-old female with a right intertrochanteric femur fracture who is taking clopidogrel 150 mg daily and aspirin 75 mg daily, how should her antiplatelet therapy be managed perioperatively?
What are the current recommendations for peri‑operative management of rivaroxaban (Xarelto) in patients undergoing hip hemiarthroplasty?
Is the combination of aspirin and rivaroxaban (Xarelto) 2.5 mg twice daily sufficient for deep‑vein thrombosis prophylaxis?
What is the recommended DVT prophylaxis and compression stocking regimen for a patient after hip fracture surgery?
What laboratory studies and diagnostic tests are indicated for a patient with a ten‑year‑old untreated iatrogenic thoracic duct injury that has leaked into the anterior mediastinum forming a chylous cyst following an anterior cervical discectomy and fusion (ACDF) at C5‑C6?
What is the differential diagnosis for an elevated blood urea nitrogen (BUN) to creatinine ratio?
What is the most likely diagnosis and appropriate evaluation and management for a 40‑year‑old woman with hemoglobin 8 g/dL, hematocrit 29.2 %, microcytic anemia (MCV 68.9 fL, MCH 18.9 pg, MCHC 27.4 g/dL), elevated RDW 17.4 % and thrombocytosis (platelet count 479 ×10⁹/L)?
What is the best approach to manage sleep disturbances in an elderly patient taking bupropion (Wellbutrin) and clonazepam (Klonopin)?
A patient on insulin U‑500 24 units twice daily (total 120 units per day) with HbA1c 8.9% wants to switch to insulin degludec (Tresiba) U‑200; how many pens should be prescribed for a 30‑day supply?
Could the patient be experiencing neuroleptic malignant syndrome (NMS) after stopping and restarting lurasidone (Latuda) 20 mg, now presenting with finger rigidity and a low‑grade fever?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.